Company Filing History:
1 out of 1 
1 out of 3 
1 out of 832,912 Years Active: 2010-2017
Title: Innovations by Cathy Federici: Pioneering Modified Release Ibuprofen
Introduction
Cathy Federici is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations for ibuprofen. With a total of three patents to her name, Federici's work focuses on enhancing the efficacy and delivery of medication.
Latest Patents
Cathy Federici's latest patents include a method for providing modified release of ibuprofen. This method involves administering a single dose of a modified release formulation that includes a hydrophilic polymer, ibuprofen in solid dosage form uniformly dispersed in the polymer, and a dissolution additive. The formulation is designed to achieve a mean ibuprofen plasma concentration of at least 6.4 µg/ml within two hours of administration and maintain this concentration for at least eight hours. Another patent focuses on a solid dosage form for oral administration of ibuprofen, which provides an immediate burst effect followed by sustained release, ensuring effective blood levels over an extended period.
Career Highlights
Throughout her career, Cathy has worked with notable companies, including Scolr Pharma, Inc. Her innovative approaches have positioned her as a key player in the pharmaceutical industry, particularly in the development of drug delivery systems.
Collaborations
Cathy has collaborated with professionals such as Michael Hite and Alan Brunelle, contributing to her success in the field. These partnerships have allowed her to enhance her research and development efforts.
Conclusion
Cathy Federici's contributions to the pharmaceutical industry through her innovative patents on ibuprofen formulations demonstrate her commitment to improving medication delivery. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.